COVID-19(13) clinical(6) prevention(4) review(4) worker(3) sequential analysis(2) Ivermectin(2) Trial(2) no difference(2) SARS-CoV-2 virus(2) suggested(2) participant(2) treatment trials(2) Prophylaxis(2) the SARS-CoV-2 virus(2) Sample(2) robust(2) adverse event(2) Digital(2) Evidence(2) Subcutaneous(2) high risk(2) journal(2) pandemic(2) reduced risk(2) SARS-CoV-2 pandemic(2) less(2) trial sequential analyses(2) severe adverse events(2) guideline(2)